Form 4 · Filed Jun 12, 2026, 09:22 PM UTC
OCUL/OCULAR THERAPEUTIX, INC
Robins Jason Shand — Chief Financial Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
2 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 10, 2026 | A | other | 15,441 | $0 | — | 68,097 |
| Jun 10, 2026 | A | other | 14,024 | — | — | 14,024 |
Source: SEC EDGAR raw filing ↗ · Accession 0001104659-26-073586